Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RAN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RAN is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, activates. Associated with Aging, Als, Amyotrophic Lateral Sclerosis. Connected to 73 entities in the SciDEX knowledge graph.
| Gene Symbol | RAN |
| Chromosome | 12q24.1 |
| Amino Acids | 216 aa |
| Exons | 8 |
| Pathways | Epigenetic, Notch, Circadian Rhythm, Tumor Microenvironment, Lipid Metabolism |
| GeneCards | RAN |
| Human Protein Atlas | RAN |
| 2019 | Partnership with Anthem (now Elevance Health) to deploy AI platform[@anthem] |
| 2020 | Launch of virtual care services in response to COVID-19 pandemic |
| 2021 | Acquisition of Hydrogen Health and Livongo assets |
| 2022 | Workforce reduction of approximately 30% |
| 2023 | Transition to profitability focus |
| 2024 | Continued expansion of primary care services |
| Associated Diseases | Aging, Als, Amyotrophic Lateral Sclerosis, Ataxia, Dementia, Huntington |
| Known Drugs/Compounds | rapamycin, metformin |
| Interactions | C9ORF72, G3BP1, Rb, RB1, RB1CC1, SMCR8 |
| KG Connections | 155 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
RAN["<b>RAN</b>"]
Als{"Als"}
RAN -->|"associated with"| Als
Ms{"Ms"}
RAN -->|"interacts with"| Ms
Amyotrophic_Lateral_Sclerosis{"Amyotrophic Lateral Sclerosis"}
RAN -->|"interacts with"| Amyotrophic_Lateral_Sclerosis
Dementia{"Dementia"}
RAN -->|"associated with"| Dementia
Ataxia{"Ataxia"}
RAN -->|"associated with"| Ataxia
Huntington{"Huntington"}
RAN -->|"associated with"| Huntington
RAN -->|"associated with"| Ms
RAN -->|"associated with"| Amyotrophic_Lateral_Sclerosis
Inflammation{"Inflammation"}
RAN -->|"inhibits"| Inflammation
RAN -->|"regulates"| Als
Neuroinflammation{"Neuroinflammation"}
RAN -->|"inhibits"| Neuroinflammation
RAN -->|"inhibits"| Amyotrophic_Lateral_Sclerosis
C9ORF72["C9ORF72"]
C9ORF72 -->|"interacts with"| RAN
C9ORF72 -->|"associated with"| RAN
P62["P62"]
P62 -->|"inhibits"| RAN
NOTCH3["NOTCH3"]
NOTCH3 -->|"associated with"| RAN
EIF2A["EIF2A"]
EIF2A -->|"inhibits"| RAN
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
NEURODEGENERATIVE_DISEASES -->|"associated with"| RAN
EIF2A -->|"activates"| RAN
ATG["ATG"]
ATG -->|"associated with"| RAN
FTLD["FTLD"]
FTLD -->|"contributes to"| RAN
NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"]
NEURODEGENERATIVE_DISORDERS -->|"associated with"| RAN
style RAN fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | associated_with | disease | 0.75 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.75 |
| ATG | associated_with | gene | 0.70 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 0.70 |
| RNA | regulates | gene | 0.70 |
| Ms | interacts_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | interacts_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | inhibits | disease | 0.65 |
| Dementia | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Hepatocellular Carcinoma | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Tauopathy | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Frontotemporal Dementia | expressed_in | disease | 0.65 |
| MARK2 | regulates | gene | 0.60 |
| C9ORF72 | regulates | gene | 0.60 |
| GAIN | associated_with | gene | 0.60 |
| DDX3X | regulates | gene | 0.60 |
| C9ORF72 | inhibits | gene | 0.60 |
| CLOCK | regulates | gene | 0.60 |
| MYC | regulates | gene | 0.60 |
| DMPK | associated_with | gene | 0.60 |
| TAU | associated_with | gene | 0.60 |
| C9ORF72 | associated_with | gene | 0.60 |
| G3BP1 | interacts_with | gene | 0.60 |
| Rb | interacts_with | protein | 0.60 |
| RB1 | activates | gene | 0.60 |
| RB1CC1 | activates | gene | 0.60 |
| SMCR8 | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| STX17 | activates | gene | 0.60 |
| TARDBP | activates | gene | 0.60 |
| TBK1 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| C9ORF72 | associated_with | gene | 0.70 |
| ATG | associated_with | gene | 0.70 |
| C9ORF72 | interacts_with | gene | 0.60 |
| P62 | inhibits | gene | 0.60 |
| NOTCH3 | associated_with | gene | 0.60 |
| EIF2A | inhibits | gene | 0.60 |
| EIF2A | activates | gene | 0.60 |
| FAS | activates | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| C9ORF72 | therapeutic_target | gene | 0.60 |
| VEGF | therapeutic_target | gene | 0.60 |
| GAIN | associated_with | gene | 0.60 |
| DMPK | associated_with | gene | 0.60 |
| TAU | associated_with | gene | 0.60 |
| CNBP | associated_with | gene | 0.60 |
| TDP43 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| FIP200 | activates | gene | 0.60 |
| DDX3X | regulates | gene | 0.60 |
| ATXN1 | expressed_in | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| FTLD | contributes_to | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | associated_with | gene | 0.60 |
| RAS | activates | gene | 0.60 |
| LIPOPHAGY | activates | gene | 0.60 |
| ALS | associated_with | gene | 0.60 |
| RUNX2 | therapeutic_target | gene | 0.60 |
| CYTOKINES | therapeutic_target | gene | 0.60 |
| IL-6 | therapeutic_target | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| TAUOPATHY | associated_with | gene | 0.60 |
| ZNF9/CNBP | associated_with | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 0.60 |
| DEMENTIA | expressed_in | gene | 0.60 |
| REPEAT-CONTAINING TRANSCRIPTS | associated_with | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | expressed_in | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| ALS | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| ATG | activates | gene | 0.60 |
| MAP1LC3 | activates | gene | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| DNA | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.583
neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.576
drug delivery | 2026-04-15 | 0 hypotheses
neuroimmunology | 2026-04-15 | 2 hypotheses Top: 0.674
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798] | Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang | Cell Mol Gastroenterol Hepatol | 2024 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] | Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia | J Inflamm Res | 2022 | 1 |
| Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466] | Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji | J Ethnopharmacol | 2022 | 1 |
| TREM2, microglia, and Alzheimer's disease. [PMID:33516818] | Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang | Mech Ageing Dev | 2021 | 1 |
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] | Wang Y, An H, Liu T, Qin C, Sesaki H, Gu | Cell Rep | 2019 | 1 |
| AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] | Song X, Zhu S, Chen P, Hou W, Wen Q, Liu | Curr Biol | 2018 | 1 |
| TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038] | Ulland TK, Song WM, Huang SC, Ulrich JD, | Cell | 2017 | 1 |
| The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] | Krasemann S, Madore C, Cialic R, Baufeld | Immunity | 2017 | 1 |
| Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664] | Cid-Díaz T, Santos-Zas I, González-Sánch | J Cachexia Sarcopenia Muscle | 2017 | 1 |
| Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and T [PMID:41833042] | ["Lyu G", "Li D"] | CNS & neurological disorders d | 2026 | 0 |
| Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuro [PMID:41858793] | ["Wang R", "Feng Y", "Zhou Z", "Jiang J" | Frontiers in aging neuroscienc | 2026 | 0 |
| Human CSF proteogenomics links genetic variation to neurodegenerative disease pr [PMID:41757182] | ["Puerta R", "Garc\u00eda-Gonz\u00e1lez | medRxiv : the preprint server | 2026 | 0 |
| PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] | Tsai AP, Martin AK, Mi A, Yeh AE, Ramire | Molecular neurodegeneration | 2026 | 0 |
| TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] | Yang HC, Deng YS, Zhang J, Zhang T, Song | J Alzheimers Dis | 2026 | 0 |
| A scalable human-zebrafish xenotransplantation model reveals gastrosome-mediated [PMID:41957412] | Villani A, Wittmann J, Wyss T, Mallona I | Commun Biol | 2026 | 0 |
| Dual Role of Microglial TREM2 in Neuronal Degeneration and Regeneration After Ax [PMID:41963086] | Pottorf TS, Lane EL, Haley-Johnson Z, Uk | J Neurosci | 2026 | 0 |
| TREM2-mediated microglial phagocytosis of inhibitory synapses contributes to pro [PMID:41965330] | Wang X, Zhou H, Zhai Y, Zhang Y, Cheng Y | Cell Death Discov | 2026 | 0 |
| Investigating the Potential of Gene Editing Technologies in Enhancing Stem Cell [PMID:41926312] | ["Mehrabadi S"] | Current aging science | 2026 | 0 |